Autoimmune pancreatitis: Optimal therapy has not been determined

American Journal of Gastroenterology

Volumn 103, Issue 7, 2008, Pages 1834-1835

  Church, Nicholas I ^a   Webster, George J M ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ACUTE PANCREATITIS; AUTOIMMUNE PANCREATITIS; BILIARY TRACT DISEASE; BONE NECROSIS; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG EFFICACY; ENTERITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LOW DRUG DOSE; NAUSEA; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; TREATMENT RESPONSE; VERTEBRA FRACTURE;

EID: 65349138187     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.01959_2.x     Document Type: Letter

References (10)

1. Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007;56:1650-2.
2. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: The Mayo clinic experience. Clin Gastroenterol Hepatol 2006;4:1010-16.
3. Kamisawa T, YoshiikeM, Egawa N, et al. Treating patients with autoimmune pancreatitis: Results from a long-term follow-up study. Pancreatology 2005;5:234-8.
4. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitiswithout andwith corticosteroid treatment. Gut 2007;56:1719-24.
5. Kamisawa T, Egawa N, Nakajima H, et al. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol 2004;39:1154-8.
6. Matsushita M, Yamashina M, Ikeura T, et al. Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis. AmJGastroenterol 2007;102:220-1.
7. Hegarty JE, Nouri Aria KT, Portmann B, et al. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology 1983;3:685-9.
8. Timmer A, McDonald JW, Macdonald JK. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2007;1:CD000478.
9. Bajaj JS, Saeian K, Varma RR, et al. Increased rates of early adverse reaction to azathioprine in patients with Crohn' s disease compared to autoimmune hepatitis: A tertiary referral center experience. Am J Gastroenterol 2005;100:1121-5.
10. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long term maintenance of remission in autoimmune hepatitis. New Engl J Med 1995;333:958-63.